Safety and physiological action of probiotics as remedies for immune correction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Disclosure of mechanisms that are used by the intestinal microbiota to maintain host immune homeostasis has established a scientific basis for the use of probiotics as immunomodulators. From the standpoint of physiological action, probiotics seem to be attractive targets for the search of effective remedies to strengthen antiinfectious immune response. The potential to cause intestinal and extraintestinal infections and to disseminate genes of antimicrobial resistance necessitates careful monitoring of probiotic strains safety. WHO, FAO, EFSA and some other international organizations have formulated the principles for assessment of probiotic safety and efficacy, which contribute to the appearance on the market of reliable remedies for the correction of immune disorders.

About the authors

O V Kalyuzhin

I.M. Sechenov First Moscow State Medical University

Email: kalyuzhin@list.ru

References

  1. Караулов А.В., Калюжин О.В. Иммунотропные препараты: принципы применения и клиническая эффективность. М., «МЦФЭР». 2007, 144 с.
  2. Караулов А.В., Сокуренко С.И., Калюжин О.В., Евсегнеева И.В. Направленная регуляция иммунных реакций в профилактике и лечении заболеваний человека. Иммунопатол., аллергол., инфектол. 2000, № 1, с. 7-13.
  3. Калюжин О.В. Возможности использования пробиотиков для укрепления противоинфекционной защиты в свете иммуногомеостатической роли микробиоты. Эффективная фармакотерапия. Аллергология и иммунология. 2013, № 2 (27/2013), с. 12-25.
  4. Калюжин О.В. Пробиотики как современные средства укрепления противоинфекционной защиты: миф или реальность? Рус. мед. журн. 2012, № 28, с. 1395-1401.
  5. Probiotics in food: Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition Paper 85, 2006.
  6. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EfSa Journal. 2012, v. 10, №. 6, art. 2740, doi: 10.2903/j.efsa.2012.2740.
  7. Sanders M.E., Akkermans L.M.A., Haller D. et al. Safety assessment of probiotics for human use. GutMicrobes. 2010, v. 1, № 3, p. 164-185, doi: 10.4161/gmic.1.3.12127.
  8. De Vrese M., Winkler P, Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacteriumbifidum MF 20/5, Bifidobacteriumlongum SP 07/3 on common cold episodes: Double blind, randomized, controlled trial. Clinical Nutrition. 2005, v. 24, p. 481-491.
  9. Wrinkler P., de Vrese M., Laue Ch., Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int. J. Clin. Pharmacol. Therapeutics. 2005, v. 43, № 7, p. 318-326.
  10. Калюжин О.В., Бунятян К.А., Инвияева Е.В. и соавт. Бион 3 в профилактике послеоперационных осложнений и коррекции расстройств иммунной системы и кишечной микробиоты у больных колоректальным раком. Курский научно-практический вестник «Человек и его здоровье». 2013, № 1, с. 67-74.

Copyright (c) 2013 Pharmarus Print Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies